TWD
True Wealth Design Portfolio holdings
AUM
$284M
1-Year Return
11.73%
This Quarter Return
-1.32%
1 Year Return
+11.73%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$258M
AUM Growth
+$1.65M
(+0.64%)
Cap. Flow
+$6.29M
Cap. Flow
% of AUM
2.44%
Top 10 Holdings %
Top 10 Hldgs %
86.39%
Holding
1,545
New
271
Increased
558
Reduced
325
Closed
195
Top Buys
Top Sells
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$718K |
| 2 |
SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
+$585K |
| 3 |
Dimensional US Small Cap Value ETF
DFSV
|
+$395K |
| 4 |
Dimensional US Targeted Value ETF
DFAT
|
+$389K |
| 5 |
T. Rowe Price Floating Rate ETF
TFLR
|
+$162K |
Sector Composition
| 1 | Technology | 2.4% |
| 2 | Industrials | 1.39% |
| 3 | Consumer Discretionary | 1.1% |
| 4 | Financials | 1.07% |
| 5 | Healthcare | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Medtronic
MDT
$121B
| $13.3K | 0.01% |
166
-402
| -71% | -$32.1K |
|
377
Reynolds Consumer Products
REYN
$4.85B
| $13.3K | 0.01% |
491
-450
| -48% | -$12.1K |
|
378
UGI
UGI
$7.36B
| $13.2K | 0.01% |
469
| – | – |
|
379
Varex Imaging
VREX
$481M
| $13.2K | 0.01% |
906
+359
| +66% | +$5.24K |
|
380
LKQ Corp
LKQ
$8.31B
| $13.1K | 0.01% |
357
+252
| +240% | +$9.26K |
|
|
BPMC
381
DELISTED
Blueprint Medicines
BPMC
| $13.1K | 0.01% |
150
+15
| +11% | +$1.31K |
|
|
BERY
382
DELISTED
Berry Global Group, Inc.
BERY
| $13.1K | 0.01% |
202
-18
| -8% | -$1.16K |
|
383
Shell
SHEL
$209B
| $13K | 0.01% |
208
+117
| +129% | +$7.33K |
|
384
Ubiquiti
UI
$36.2B
| $12.9K | 0.01% |
39
-6
| -13% | -$1.99K |
|
385
TJX Companies
TJX
$156B
| $12.9K | 0.01% |
107
+12
| +13% | +$1.45K |
|
386
Novo Nordisk
NVO
$241B
| $12.9K | 0.01% |
150
+2
| +1% | +$172 |
|
387
Light & Wonder
LNW
$7.39B
| $12.9K | 0.01% |
149
-161
| -52% | -$13.9K |
|
388
WESCO International
WCC
$10.3B
| $12.8K | 0.01% |
71
+57
| +407% | +$10.3K |
|
389
Essent Group
ESNT
$6.21B
| $12.8K | 0.01% |
236
+172
| +269% | +$9.36K |
|
390
Morgan Stanley
MS
$243B
| $12.6K | ﹤0.01% |
100
+13
| +15% | +$1.63K |
|
391
Novartis
NVS
$248B
| $12.6K | ﹤0.01% |
129
+27
| +26% | +$2.63K |
|
392
FTI Consulting
FCN
$5.41B
| $12.4K | ﹤0.01% |
65
-101
| -61% | -$19.3K |
|
393
Newell Brands
NWL
$2.61B
| $12.4K | ﹤0.01% |
1,241
| – | – |
|
394
Commault Systems
CVLT
$8.23B
| $11.9K | ﹤0.01% |
79
+6
| +8% | +$905 |
|
395
Middleby
MIDD
$7.03B
| $11.8K | ﹤0.01% |
+87
| New | +$11.8K |
|
396
J.M. Smucker
SJM
$11.8B
| $11.8K | ﹤0.01% |
107
-7
| -6% | -$771 |
|
397
ManpowerGroup
MAN
$1.78B
| $11.7K | ﹤0.01% |
203
+92
| +83% | +$5.31K |
|
398
Argan
AGX
$3B
| $11.6K | ﹤0.01% |
85
+6
| +8% | +$822 |
|
399
Masimo
MASI
$8.05B
| $11.6K | ﹤0.01% |
70
| – | – |
|
400
Cerence
CRNC
$418M
| $11.5K | ﹤0.01% |
1,469
+11
| +0.8% | +$86 |
|